Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 08 07 2022
accepted: 22 08 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Asymptomatic and pre-symptomatic SARS-CoV-2 infections may contribute to ongoing community transmission, however, the benefit of routine screening of asymptomatic individuals in low-risk populations is unclear. To identify SARS-CoV-2 infections 553 seronegative individuals were prospectively followed for 52 weeks. From 4/2020-7/2021, participants submitted weekly self-collected nasal swabs for rtPCR and completed symptom and exposure surveys. Incident SARS2-CoV-2 infections were identified in 9/553 (1.6%) participants. Comparisons of SARS2-CoV-2(+) to SARS2-CoV-2(-) participants revealed significantly more close contacts outside the household (median: 5 versus 3; p = 0.005). The incidence of infection was higher among unvaccinated/partially vaccinated than among fully vaccinated participants (9/7,679 versus 0/6,845 person-weeks; p = 0.004). At notification of positive test result, eight cases were symptomatic and one pre-symptomatic. These data suggest that weekly SARS2-CoV2 surveillance by rtPCR did not efficiently detect pre-symptomatic infections in unvaccinated participants.

Sections du résumé

BACKGROUND
Asymptomatic and pre-symptomatic SARS-CoV-2 infections may contribute to ongoing community transmission, however, the benefit of routine screening of asymptomatic individuals in low-risk populations is unclear.
METHODS
To identify SARS-CoV-2 infections 553 seronegative individuals were prospectively followed for 52 weeks. From 4/2020-7/2021, participants submitted weekly self-collected nasal swabs for rtPCR and completed symptom and exposure surveys.
RESULTS
Incident SARS2-CoV-2 infections were identified in 9/553 (1.6%) participants. Comparisons of SARS2-CoV-2(+) to SARS2-CoV-2(-) participants revealed significantly more close contacts outside the household (median: 5 versus 3; p = 0.005). The incidence of infection was higher among unvaccinated/partially vaccinated than among fully vaccinated participants (9/7,679 versus 0/6,845 person-weeks; p = 0.004). At notification of positive test result, eight cases were symptomatic and one pre-symptomatic.
CONCLUSIONS
These data suggest that weekly SARS2-CoV2 surveillance by rtPCR did not efficiently detect pre-symptomatic infections in unvaccinated participants.

Identifiants

pubmed: 36155639
doi: 10.1371/journal.pone.0274078
pii: PONE-D-22-19281
pmc: PMC9512209
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0274078

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI135072
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002317
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR002318
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Clin Infect Dis. 2022 Jan 7;74(1):52-58
pubmed: 33822007
Lancet. 2022 Mar 5;399(10328):924-944
pubmed: 35202601
JAMA Netw Open. 2021 Sep 1;4(9):e2126447
pubmed: 34550382
N Engl J Med. 2021 Nov 4;385(19):1761-1773
pubmed: 34525277
Lancet. 2020 May 23;395(10237):1608-1610
pubmed: 32401714
JAMA Netw Open. 2022 Jan 4;5(1):e2142057
pubmed: 34982157
Sci Rep. 2022 Apr 8;12(1):5936
pubmed: 35395856
J Med Virol. 2022 May;94(5):1876-1885
pubmed: 35083761
Nature. 2021 Nov;599(7883):114-119
pubmed: 34488225
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33219112
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
BMC Med. 2021 Apr 27;19(1):106
pubmed: 33902581
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34):
pubmed: 34376550

Auteurs

Whitney E Harrington (WE)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.

Winnie Yeung (W)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Ingrid A Beck (IA)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Fred D Mast (FD)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

John Houck (J)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Sheila Styrchak (S)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Leslie R Miller (LR)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Song Li (S)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Micaela Haglund (M)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Yonghou Jiang (Y)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Blair Armistead (B)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Jackson Wallner (J)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Tina Nguyen (T)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Daisy Ko (D)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Samantha Hardy (S)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Alyssa Oldroyd (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

Ana Gervassi (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.

John D Aitchison (JD)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.
Department of Biochemistry, University of Washington, Seattle, Washington, United States of America.

Lisa M Frenkel (LM)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, United States of America.
Department of Pediatrics, University of Washington, Seattle, Washington, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH